GlassScriptPhysician profile
Travis Joseph Miller
NPI 1437546561
$6,338.60
in general payments reported to CMS, 2019-2025
19 companies · $2,466 in 2025
The $2,466 reported for 2025 was more than what 87% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $1,073 · 2021: $146 · 2022: $90.37 · 2023: $90.00 · 2024: $2,189 · 2025: $2,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021 · Long Term Medical Supply Or Device Loan: $1,628 · Travel and Lodging: $1,007 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,020.86 |
| Long Term Medical Supply Or Device Loan | $1,628.16 |
| Travel and Lodging | $1,006.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,834.81 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $1,313.21 | 2021-2025 | Phasix Mesh |
| Evolution Surgical, INC | $1,072.80 | 2020 | |
| Tela Bio, INC. | $371.46 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $321.95 | 2025 | |
| Endo Pharmaceuticals INC. | $199.58 | 2019 | |
| Polynovo North America LLC | $182.09 | 2024-2025 | Novosorb Btm |
| Abbvie INC. | $177.47 | 2025 | |
| Organogenesis INC. | $148.83 | 2024 | |
| Smith+Nephew, INC. | $136.60 | 2024 | Stravix |
| Acumed LLC | $118.81 | 2024 | Acumed |
| Biocircuit Technologies INC | $111.58 | 2025 | Nerve Tape |
| Becton, Dickinson and Company | $90.00 | 2023 | Bd Safetyglide |
| Pfizer INC. | $84.57 | 2019 | |
| Allergan, INC. | $47.76 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $43.62 | 2025 | Gore Synecor Biomaterial |
| Sonex Health, INC. | $42.61 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.47 | 2024 | Ninlaro |
| Daiichi Sankyo INC. | $20.38 | 2025 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.